Protagonist Therapeutics Inc

PTGX

Healthcare|Biotechnology|USA

$131.42

-6.22 (-4.52%)

DCF (FCF)

$3.72

Tangible Book

$10.21

Clinical Trials (14)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug
NCT05210790 A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera	Polycythemia Vera	P3	Active	293	RCT, Double-blind	Placebo, Rusfertide
NCT06033586 Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera	Polycythemia Vera	P3	Active	46	Open-label	Open-label rusfertide
NCT07153146 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.	Healthy Volunteer	P1	Recruiting	142	RCT, Double-blind	PN-881 Oral Solution, PN-881 Oral Tablet, Placebo
NCT02895100 Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis	Ulcerative Colitis	P2	Terminated	98	RCT, Double-blind	PTG-100, Placebo
NCT04504383 PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)	Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe	P2	Completed	169	RCT, Double-blind	PN-943, Placebo
NCT04054921 Safety Study for Beta Thalassemia Subjects on PTG-300	β-thalassemia, Ineffective Erythropoiesis	P2	Completed	34	Open-label	PTG-300
NCT04057040 Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)	Polycythemia Vera	P2	Completed	70	RCT, Double-blind	PTG-300, Placebo
NCT04767802 PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit	Polycythemia Vera	P2	Completed	20	Open-label	PTG-300
NCT04202965 PTG-300 in Subjects With Hereditary Hemochromatosis	Hereditary Hemochromatosis	P2	Completed	16	Open-label	PTG-300
NCT03802201 Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia	β-thalassemia, Ineffective Erythropoiesis	P2	Completed	63	Open-label	PTG-300
NCT04621630 Pharmacokinetics of PN-235 in Healthy Volunteers	Healthy Volunteers	P1	Completed	107	RCT, Double-blind	PN-235, Placebo
NCT04819620 Pharmacokinetics of PN-232 in Healthy Volunteers	Healthy Subjects	P1	Completed	48	RCT, Double-blind	PN-232, Placebo
NCT04524221 PTG-100 for Patients With Celiac Disease	Celiac Disease	P1	Completed	12	RCT, Double-blind	PTG-100, Placebo
NCT04516382 Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers	Healthy Volunteers	P1	Completed	12	Open-label	PTG-300